Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Maceron Jan 23, 2020 7:58pm
154 Views
Post# 30591610

RE:RE:How about some really good news TLT . TIA

RE:RE:How about some really good news TLT . TIA

CAinPlap wrote: Agreed. News of trial progression will be what moves shareprice and not cups and handles or heads and shoulders or all that other voodoo. No offence to you chartists but I just want patients treated. 
I've asked before what people feel the bottle neck in the trial is but no one bit.
Choices are:
 - lack of qualified willing patients
 - lack of qualified Doctors and treatment rooms
 - by trial design, i.e. need feedback from patient 1 to 3 before patients 4 to 6 are treated or something to that effect
Cheers!


i have provided this information multiple times.
FACT: the inclusion criteria for the trial is such that even if all the bladder cancer patients and all of the MD's referred patients to trial centers there would still be only a handful of patients treated because of the inclusion criteria.We need more geography and population to get more patients. It's that simple.
macer

 

Bullboard Posts